Citi analyst Mathieu Chevrier upgraded Pro Medicus to Neutral from Sell with an unchanged price target of A$61. The analyst cites the recent decline in the shares for the upgrade.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on PMCUF: